This is a type of cancer that starts in the deep tissue that holds your body together, like the connective tissue. It's made up of immature cells called fibroblasts. These cells grow out of control and can spread to other parts of the body.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Fibrosarcoma?
Fibrosarcoma is a rare cancer that starts in fibroblasts, the cells that make the fibrous tissue holding muscles, tendons and other body structures together. It belongs to the soft tissue sarcomas, a large family of cancers of connective tissue. It usually first shows up as a lump, often painless, under the skin of an arm, a leg or the trunk. As it grows and presses on nearby muscles, nerves or organs, it can cause pain, weakness or other problems that depend on where it is. The name covers two quite different diseases. Infantile fibrosarcoma affects babies, usually in the first year of life, and is sometimes present at birth or seen on a prenatal ultrasound. It tends to grow quickly and can be large, but it rarely spreads to distant parts of the body and usually has a very good outlook. Adult-type fibrosarcoma occurs mainly in adults and occasionally in older children. It is more aggressive: high-grade tumors can spread through the bloodstream to other organs. Several other tumors have similar names, including dermatofibrosarcoma protuberans, myxofibrosarcoma and low-grade fibromyxoid sarcoma. They are separate diagnoses with their own behavior and treatment, so the exact wording of the pathology report matters.
In most people no specific cause is found. Infantile fibrosarcoma is driven by a genetic change inside the tumor cells: usually two genes, ETV6 and NTRK3, become joined into one abnormal gene that keeps switching on cell growth. This kind of joined gene is called a fusion. Finding it helps confirm the diagnosis, and it also matters for treatment. For soft tissue sarcomas in general, known risk factors include past radiation therapy, certain inherited conditions such as Li-Fraumeni syndrome, long-standing lymphedema (chronic swelling of an arm or leg) and exposure to some chemicals, such as vinyl chloride. These raise risk across the sarcoma family; how much each contributes to fibrosarcoma specifically is not well established. A sarcoma can also develop in someone with no known risk factor.
Evaluation of a suspicious lump usually starts with imaging. MRI shows the size of the tumor and how it sits against muscles, nerves and blood vessels; CT, ultrasound or X-rays may also be used. Scans such as a chest CT or PET-CT help show whether the cancer has spread, which affects treatment. The diagnosis itself requires a biopsy, often a core needle biopsy that removes small strips of tissue through a wide needle. A pathologist examines the cells under a microscope and with special stains and genetic tests. Adult-type fibrosarcoma is a diagnosis of exclusion: it resembles several other tumors made of long, spindle-shaped cells, so it is named only after those have been ruled out. Infantile tumors are tested for the ETV6 and NTRK3 fusion or related gene changes. Some adult-type tumors also carry an NTRK fusion, so testing can matter in adults too. Adult tumors are given a grade from 1 (low) to 3 (high), based on how abnormal the cells look, how fast they divide and how much of the tumor has died off. Higher-grade tumors behave more aggressively. Grade, size, depth and any spread together set the stage, which guides treatment.
For infantile fibrosarcoma, completely removing the tumor cures most children. The difficulty is that these tumors are often large, and removing them outright could cost important function or, for a tumor in a limb, require amputation. Treatment is therefore often staged: medicine first to shrink the tumor, then a more limited operation. Chemotherapy works well against this tumor. Larotrectinib (Vitrakvi) is a targeted medicine, taken by mouth, that blocks the overactive protein made by an NTRK fusion; it is used only when testing confirms such a fusion. In a children's cancer trial, the tumor shrank in 17 of 18 babies with infantile fibrosarcoma, and some could then have less extensive surgery. It needs regular blood tests, because it can affect the liver, and attention to side effects such as dizziness. When only microscopic traces of tumor remain after surgery, careful observation without further treatment is sometimes an option. For adult-type fibrosarcoma, the main treatment is surgery to remove the tumor with a margin of healthy tissue around it, because cancer left at the edges raises the chance it returns. Radiation therapy is usually added for tumors larger than 5 cm (about 2 inches), deep tumors or high-grade tumors, to lower the chance of the cancer coming back in the same place. This tumor responds relatively poorly to chemotherapy, but standard sarcoma chemotherapy such as doxorubicin may still be used for high-grade tumors or cancer that has spread. When testing finds an NTRK fusion, larotrectinib or entrectinib (Rozlytrek), another targeted medicine of the same kind, may be options. For advanced disease, surgery or radiation can also relieve pain or pressure, and clinical trials are worth asking about.
For babies with infantile fibrosarcoma, the long-term outlook is generally excellent, especially when the tumor appears at age 4 or younger. Treatment can still be demanding for a family, involving months of medicine, surgery or both, and children who needed major surgery may need ongoing support for how the affected limb or area works. Adult-type fibrosarcoma is a more serious diagnosis. The outlook depends mainly on the tumor's grade and size, how deep it lies, whether it could be removed completely and whether it had spread at diagnosis. Small, low-grade tumors that are fully removed do best; high-grade tumors are more likely to come back or spread. Recovery depends on where the tumor was and how extensive the surgery and radiation were. After treatment, follow-up visits with examinations and scans continue for some time to check whether the cancer has returned. A large US cancer registry study found more second cancers than expected among people treated for adult-type fibrosarcoma, though not after infantile fibrosarcoma, which is one more reason to keep up with follow-up care.
See a doctor about a lump that keeps growing or causes pain or weakness, and about any lump or swelling in a baby that grows quickly. Many other conditions cause lumps, but a growing one deserves imaging rather than waiting. During or after treatment, contact the care team promptly about a new lump or swelling near the treated area, new trouble breathing or a cough that does not go away, or medicine side effects such as marked dizziness, confusion or yellowing of the skin or eyes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fibrosarcoma is like, what's helped you, or ask the community a question.